ANEB

Anebulo Pharmaceuticals Inc

NASDAQ: ANEB · HEALTHCARE · BIOTECHNOLOGY

$0.28

+5.77% today

Updated 2026-10-28

Market cap

$22.43M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.18

Dividend yield

—

52W range

$0 – $3

Volume

0.0M

Market cap

$22.43M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.18

Dividend yield

—

52W range

$0 – $3

Volume

0.0M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

6.0

Quality

3.0

Profitability

5.0

Valuation

C+

3/9

Piotroski F-Score

Weak

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →270 stocks currently score above 75

Price targets

Analyst target

$3.00

+990.91%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

Stock snapshot

Strengths

Insufficient data

Risks

- Piotroski 3/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-1.31M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-6.83M	$-11.73M	$-8.20M	$-8.48M	$-2.00M
EPS	—	—	—	—	$-0.18
Free cash flow	$-5.44M	$-9.68M	$-8.09M	$-6.35M	$-1.31M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
ANEB	$22.43M	25	4.3	3.0	5.0	6.0	—	Avoid
LLY	$1.12T	76	9.3	10.0	5.0	6.0	—	Strong Buy
JNJ	$615.87B	57	4.7	8.5	2.7	5.5	-83.05%	Buy
ABBV	$504.37B	73	6.7	8.5	4.0	5.0	-86.73%	Strong Buy
UNH	$360.32B	62	6.7	6.0	4.7	5.5	-25.92%	Buy
MRK	$360.08B	36	4.0	4.5	2.0	5.0	-73.68%	Hold

Smart narrative

Anebulo Pharmaceuticals Inc trades at $0.28. Our Smart Value Score of 25/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score.

Frequently asked questions

What is Anebulo Pharmaceuticals Inc's stock price?

Anebulo Pharmaceuticals Inc (ANEB) trades at $0.28.

Is Anebulo Pharmaceuticals Inc overvalued?

Anebulo Pharmaceuticals Inc carries a Smart Value Score of 25/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Anebulo Pharmaceuticals Inc (ANEB)?

The 12-month analyst consensus target is $3.00, about 990.9% above the current $0.28. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-100.53%

Beta-0.70

50D MA$0.76

200D MA$1.82

Shares out0.04B

Float0.00B

Short ratio—

Avg volume0.0M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

ANEB vs LLY →ANEB vs JNJ →ANEB vs ABBV →Stock screener →